Changes of telomerase activity by alternative splicing of full-length and β variants of hTERT in breast cancer patients

Oncology Research

Volumn 18, Issue 5-6, 2009, Pages 213-220

  Rha, Sun Young ^a,b   Jeung, Hei Cheul ^a,b   Park, Kyu Hyun ^a   Kim, Jin Ju ^c   Chung, Hyun Cheol ^a,b  

^a Yonsei University College of Medicine   (South Korea)

^b Yonsei University College of Medicine   (South Korea)

^c Inha University School of Medicine   (South Korea)

Author keywords

Alternative splicing; Breast cancer; Full length; hTERT; variant

Indexed keywords

TELOMERASE; TERT PROTEIN, HUMAN;

ADULT; AGED; ALTERNATIVE RNA SPLICING; ARTICLE; BREAST CANCER; CLINICAL ARTICLE; ENZYME ACTIVITY; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TELOMERE; TELOMERIC REPEAT AMPLIFICATION PROTOCOL; BREAST TUMOR; ENZYMOLOGY; GENE EXPRESSION REGULATION; GENETIC TRANSCRIPTION; GENETICS; LUNG CARCINOMA; METABOLISM; MIDDLE AGED; PAGET NIPPLE DISEASE; PATHOLOGY; PROGNOSIS;

ADULT; AGED; ALTERNATIVE SPLICING; BREAST NEOPLASMS; CARCINOMA, DUCTAL, BREAST; CARCINOMA, LOBULAR; FEMALE; GENE EXPRESSION REGULATION, ENZYMOLOGIC; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MIDDLE AGED; PROGNOSIS; TELOMERASE; TELOMERE; TRANSCRIPTION, GENETIC;

EID: 77951219259     PISSN: 09650407     EISSN: None     Source Type: Journal    
DOI: 10.3727/096504009X12596189659123     Document Type: Article

References (32)

1. Yeo, M.; Rha, S.; Jeung, H.; Shen, X.; Yang, S.; An, S.; Roh, J.; Chung, H. Different role of functional domains of hTR in DNA bidning to telomere and telomerase reconstruction. FEBS Lett. 579:127-132; 2005. (Pubitemid 40023384)
2. Yeo, M.; Rha, S.; Jeung, H.; Hu, S.; Yang, S.; Kim, Y.; An, S.; Chung, H. Attenuation of telomerase activity by hammerhead ribozyme targeting human telomerase RNA induces growth retardation and apoptosis in human breast tumor cells. Int. J. Cancer 114:484-489; 2005.
3. Ji, H.; Rha, S.; Jeung, H.; Yang, S.; An, S.; Chung, H. Cyclic induction of senescence with intermittent AZT treatment accelerates both apoptosis and telomere loss. Breast Cancer Res. Treat. 93:227-236; 2005.
4. Kilian, A.; Bowtell, D.; Abud, H.; Hime, G.; Venter, D.; Keese, P.; Duncan, E.; Reddel, R.; Jefferson, R. Isolation of a candidate human telomerase catalytic subunit gene, which reveals complex splicing patterns in different cell types. Hum. Mol. Genet. 6:2011-2019; 1997.
5. Ulaner, G.; Hu, J.; Vu, T.; Giudice, L.; Hoffman, A. Telomerase activity in human development is regulated by phehuman telomerase reverse transcriptase (hTERT) trannomenon scription and by alternate splicing of hTERT transcripts. Cancer Res. 58:4168-4172; 1998. (Pubitemid 28440575)
6. Ulaner, G.; Hu, J.; Vu, T.; Giudice, L.; Hoffman, A. Tis- inconsissue-specific alternate splicing of human telomerase reverse transcriptase (hTERT) influences telomere lengths during human development. Int. J. Cancer 91:644-649; 2001.
7. Park, K.; Rha, S.; Kim, C.; Kim, T.; Yoo, N.; Kim, J.; Roh, J.; Noh, S.; Min, J.; Lee, K.; Kim, B.; Chung, H. Telomerase activity and telomere lengths in various cell lines: changes of telomerase activity can be another method for chemosensitivity evaluation. Int. J. Oncol. 13:489-495; 1998.
8. Rha, S.; Park, K.; Kim, T.; Yoo, N.; Yang, W.; Roh, J.; Min, J.; Lee, K.; Kim, B.; Choi, J.; Lim, H.; Chung, H. Changes of telomerase and telomere lengths in paired normal and cancer tissues of breast. Int. J. Oncol. 15:839-845; 1999.
9. Shim, W.; Park, K.; Jeung, H.; Kim, Y.; Kim, T.; Hyung, W.; An, S.; Yang, S.; Noh, S.; Chung, H.; Rha, S. Quantitative detection of telomerase activity by real-time TRAP assay in the body fluids of cancer patients. Int. J. Mol. Med. 16:857-863; 2005.
10. Wang, Z.; Kyo, S.; Maida, Y.; Takakura, M.; Tanaka, M.; Yatabe, N.; Kanaya, T.; Nakamura, M.; Koike, K.; Hisamato, K.; Ohmichi, M.; Inoue, M. Tamoxifen regulates human telomerase reverse transcriptase (hTERT) gene expression differently in breast and endometrial cancer cells. Oncogene 21:3517-3524; 2002.
11. Brenner, C.; Wolny, Y.; Adler, R.; Cohen, J. Alternative splicing of the telomerase catalytic subunit in human oocytes and embryos. Mol. Hum. Reprod. 5:845-850; 1999.
12. Weinrich, S.; Pruzan, R.; Ma, L.; Ouellette, M.; Tesmer, V.; Holt, S.; Bodnar, A.; Lichtsteiner, S.; Kim, N.; Trager, J.; Taylor, R.; Carlos, R.; Andrews, W.; Wright, W.; Shay, J.; Harley, C.; Morin, G. Reconstitution of human telomerase with the template RNA component hTR and the catalytic protein subunit hTRT. Nat. Genet. 17:498-502; 1997.
13. Rha, S.; Jeung, H.; Yang, W.; Kim, J.; Oh, T.; An, S.; Chung, H. Alteration of hTERT full-length variant expression level showed different gene expression profiles and genomic copy number changes in breast cancer. Oncol. Rep. 15:749-755; 2006.
14. Yi, X.; Shay, J.; Wright, W. Quantitation of telomerase components and hTERT mRNA splicing patterns in immortal human cells. Nucleic Acid Res. 29:4818-4825; 2001. (Pubitemid 33133553)
15. Ding, Z.; Green, A.; Yang, X.; Chernenko, G.; Tang, S.; Pater, A. Retinoic acid inhibits telomerase activity and downregulates expression but does not affect splicing of hTERT: Correlation with cell growth rate inhibition in an in vitro cervical carcinogenesis/multidrug-resistance model. Exp. Cell Res. 272:185-191; 2002.
16. Hara, T.; Noma, T.; Yamashiro, Y.; Naito, K.; Nakazawa, A. Quantitative analysis of telomerae activity and telomerase reverse transcriptase expression in renal cell carcinoma. Urol. Res. 29:1-6; 2001.
17. Zaffaroni, N.; Della, P.; Villa, R.; Botti, C.; Buglioni, S.; Mottolese, M.; Grazia, D. Transcription and alternative splicing of telomerase reverse transcriptase in benign and malignant breast tumours and in adjacent mammary glandular tissues: implications for telomerase activity. J. Pathol. 198:37-46; 2002.
18. Strati, A.; Papoutsi, Z.; Lianidou, E.; Moutsatsou, P. Effect of ellagic acid on the expression of human telomerase reverse transcriptase (hTERT) α+β+ transcript in extrogen receptor-positive MCF-7 breast cancer cells. Clin. Biochem. 42:1358-1362; 2009.
19. Yokoyama, Y.; Wan, X.; Takahashi, Y.; Shinohara, A.; Tamaya, T. Alternatively spliced variant deleting exon 7 and 8 of the human telomerase reverse transcriptase gene is dominantly expressed in the uterus. Mol. Hum. Reprod. 7:853-857; 2001.
20. Krams, M.; Claviez, A.; Heidorn, K.; Krupp, G.; Parwaresch, R.; Harms, D.; Rudolph, P. Regulation of telomerase activity by alternate splicing of human telomerase reverse transcriptase mRNA in a subset of neuroblastomas. Am. J. Pathol. 159:1925-1932; 2001.
21. Wright, W.; Shay, J.; Piatyszek, M. Modifications of a telomeric repeat amplification protocol (TRAP) result in increased reliability, linearity and sensitivity. Nucleic Acid Res. 23:3794-3795; 1995.
22. Shin, H.; Jung, K.; Won, Y.; Kong, H.; Yim, S.; Sung, J.; Seo, S.; Kim, K.; Lee, S.; Kong, I.; Hwang, I.; Lee, C.; Woo, Z.; Lee, T.; Choi, J.; Yoo, C.; Bae, J.; Yoo, K. National cancer incidence for the year 2002 in Korea. Cancer Res. Treat. 39:139-149; 2007.
23. Ahn, S.; Yoo, K.; Korean Breast cancer Society. Chronological changes of clinical characteristics in 31,115 new breast cancer patients among Koreans during 1996-2004. Breast Cancer Res. Treat. 99:209-214; 2006.
24. 3/6-p38-signaling cascade alters the subcellular distribution of hnRNP A1 and modulates alternative splicing regulation. J. Cell. Biol. 149:307-316; 2000.
25. Jalink, M.; Ge, Z.; Liu, C.; Bjorkholm, M.; Gruber, A.; Xu, D. Human normal T lymphocutes and lymphoid cell lines do express alternative splicing variants of human telomerase reverse transcriptase (hTERT) mRNA. Biochem. Biophys. Res. Commun. 353:999-1003; 2007.
26. Saeboe-Lassen, S.; Fossberg, E.; Gaudernack, G. Characterization of novel alternative splicing sites in human telomerase reverse transcriptase (hTERT): Analysis of expression and mutual correlation in mRNA isoforms from normal and tumor tissues. BMC Mol. Biol. 7:26; 2006.
27. Shervington, A.; Patel, R. Differential hTERT mRNA processing between young and older glioma patients. FEBS Lett. 582:1707-1710; 2008.
28. Yi, X.; White, D. M.; Aisner, D. L.; Baur, J. A.; Wright, W. E.; Shay, J. W. An alternate splicing variant of the human telomerase catalytic subunit inhibits telomerase activity. Neoplasia 2:433-440; 2000.
29. Colgin, L. M.; Wilkinson, C.; Englezou, A.; Kilian, A.; Robinson, M. O.; Reddel, R. R. The hTERTα splice variant is a dominant negative inhibitor of telomerase activity. Neoplasia 2:426-432; 2000.
30. Beattie, T. L.; Zhou, W.; Robinson, M. O.; Harrington, L. Functional multimerization of the human telomerase reverse transcriptase. Mol. Cell. Biol. 21:6151-6160; 2002.
31. Ulaner, G. A.; Hu, J. F.; Vu, T. H.; Oruganti, H.; Giudice, L. C.; Hoffman, A. R. Regulation of telomerase by alternate splicing of human telomerase reverse transcriptase (hTERT) in normal and neoplastic ovary, endometrium and myometrium. Int. J. Cancer 85:330-335; 2000.
32. Villa, R.; Porta, C. D.; Folini, M.; Daidone, M. G.; Zaffaroni, N. Possible regulation of telomerase activity by transcription and alternatively splicing of telomerase reverse transcriptase in human melanoma. J. Invest. Dermatol. 116:867-873; 2001.